fair enough - I think manufacturing shouldn’t be an issue. It clearly has the advantage in that area. I think it’s more the logistics and supply chain of the drug that will make it tricky to commercialise. It has a longer half life but it is still time sensitive.
Personally, it’s not something that I know too much about but that would definitely be something Pharma companies will look for as well as the manufacturing.
- Forums
- ASX - By Stock
- Research/Valuation
fair enough - I think manufacturing shouldn’t be an issue. It...
-
-
- There are more pages in this discussion • 632 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
|
|||||
Last
$6.67 |
Change
-0.230(3.33%) |
Mkt cap ! $2.103B |
Open | High | Low | Value | Volume |
$6.85 | $6.91 | $6.65 | $6.534M | 965.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 12427 | $6.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.68 | 38 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 12427 | 6.670 |
5 | 8178 | 6.650 |
5 | 8956 | 6.640 |
2 | 23951 | 6.630 |
1 | 300 | 6.620 |
Price($) | Vol. | No. |
---|---|---|
6.680 | 38 | 2 |
6.700 | 3394 | 3 |
6.740 | 18697 | 1 |
6.750 | 2000 | 1 |
6.770 | 8551 | 3 |
Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |